In Brief: Novartis
Executive Summary
Novartis: David Parkinson, MD, to VP-clinical research, oncology. Parkinson most recently was acting associate director of the National Cancer Institute's Cancer Therapy Evaluation Program; previously, he was chief of the NCI's Investigational Drugs Branch and chairman of FDA's Biologics Advisory Committee...